Qi An
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qi An has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Mingwei Jin
Department of Pediatrics, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China
4 shared publicationsShumei Xu
Department of Pediatrics, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China
3 shared publicationsLei Wang
Department of Pediatric Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China
2 shared publicationsM. -W. Jin
Department of Pediatrics, Xuzhou Children's Hospital, Xuzhou, Jiangsu, P.R. China.
2 shared publicationsS. -M. Xu
Xuzhou Childrens Hosp, Dept Pediat, Xuzhou, Jiangsu, Peoples R China
2 shared publicationsC. -M. Xuan
Xuzhou Childrens Hosp, Dept Hematol, Xuzhou, Jiangsu, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 7 June 2021
- Published by Spandidos Publications in Oncology Letters
- Vol. 22 (2) , 1
[Corrigendum] Pediatric haematopoiesis and related malignancies
[This corrects the article DOI: 10.3892/ol.2017.6106.].
- 7 June 2021
- Published by Spandidos Publications in Oncology Letters
- Vol. 22 (2) , 1
Open Access[Corrigendum] Pediatric haematopoiesis and related malignancies
[This corrects the article DOI: 10.3892/ol.2017.6106.].
- 1 October 2019
- Published by Edizioni Minerva Medica in Minerva Pediatrica
- Vol. 71 (5) , 470-474
Central nervous system disease in childhood acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the commonest childhood malignancy. Despite therapeutic advancements, relapse of the pathological state in the form of central nervous system (CNS) disease remains a challenge. CNS disease appears to be present at diagnosis in at least 40% of patients. This relapse in the form of CNS disease is one of the major hurdles in achieving complete cure. The present review article aims to discuss the important mechanisms of leukemic entry and infiltration patterns of leukemic cells into the CNS. Also, latest updates in the management strategies of ALL will also be focused in the present article.
- 1 October 2019
- Published by Edizioni Minerva Medica in Minerva Pediatrica
- Vol. 71 (5) , 470-474
Central nervous system disease in childhood acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the commonest childhood malignancy. Despite therapeutic advancements, relapse of the pathological state in the form of central nervous system (CNS) disease remains a challenge. CNS disease appears to be present at diagnosis in at least 40% of patients. This relapse in the form of CNS disease is one of the major hurdles in achieving complete cure. The present review article aims to discuss the important mechanisms of leukemic entry and infiltration patterns of leukemic cells into the CNS. Also, latest updates in the management strategies of ALL will also be focused in the present article.
- 1 September 2018
- Vol. 22 (18) , 6015-6019
Central nervous disease in pediatric patients during acute lymphoblastic leukemia (ALL): a review
Acute lymphoblastic leukemia (ALL) is one of the frequently reported malignancies of childhood age. Earlier it was thought to be a fatal pathological state with no cure, but with advancements in medicine and science, new therapeutic approaches have resulted in better management and cure. However, one of the major hurdles in achieving a complete cure is the relapse of ALL at extra-medullary sites like the central nervous system (CNS). The present review article is focused on recent diagnostic avenues available for the detection of CNS disease during acute lymphoblastic leukemia (ALL) in young patients.
- 1 September 2018
- Vol. 22 (18) , 6015-6019
Central nervous disease in pediatric patients during acute lymphoblastic leukemia (ALL): a review
Acute lymphoblastic leukemia (ALL) is one of the frequently reported malignancies of childhood age. Earlier it was thought to be a fatal pathological state with no cure, but with advancements in medicine and science, new therapeutic approaches have resulted in better management and cure. However, one of the major hurdles in achieving a complete cure is the relapse of ALL at extra-medullary sites like the central nervous system (CNS). The present review article is focused on recent diagnostic avenues available for the detection of CNS disease during acute lymphoblastic leukemia (ALL) in young patients.
- 1 April 2018
- Vol. 22 (7) , 2000-2004
Lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) and its clinical significance
OBJECTIVE: To study the peripheral blood lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) in acute period as well as remission period, and compare them with healthy children to investigate the significance of lymphocyte subsets in the diagnosis, treatment, and prognosis in children with HLH. PATIENTS AND METHODS: From January 2009 to March 2014, 30 HLH patients were enrolled in this study. Among them, 20 were placed in the remission group, while 10 cases were placed in the death group. 6 cases died within 8 weeks due to the illness, and 4 cases died within 9 to 34 weeks. 30 children who were confirmed healthy after physical check-ups in the same period were enrolled in the control group. Peripheral blood was collected from both groups and lymphocyte subsets were studied using flow cytometry. RESULTS: The ratios of CD3+ T and CD8+ T cells increased in the HLH remission group and the death group, while CD4+, CD4+/CD8+ and CD3-CD16+ CD56+ NK ratios decreased. Difference detected in the proportion of CD19+ B cells was not statistically significant. By comparing lymphocyte subsets in the HLH acute period and the remission period in HLH patients we discovered that the differences in CD3+, CD8+, CD4+ and CD4+/CD8+, CD19+ B cells ratios were not statistically significant (p > 0.05). CD3-CD16+ CD56+ NK cells ratios in the remission period increased significantly. CONCLUSIONS: The lymphocyte subsets in children with HLH underwent obvious changes and there was an imbalance in cellular immunity. We believe that dynamic detection of changes may help us to evaluate the prognosis and the effect of the treatment.
- 1 April 2018
- Vol. 22 (7) , 2000-2004
Lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) and its clinical significance
OBJECTIVE: To study the peripheral blood lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) in acute period as well as remission period, and compare them with healthy children to investigate the significance of lymphocyte subsets in the diagnosis, treatment, and prognosis in children with HLH. PATIENTS AND METHODS: From January 2009 to March 2014, 30 HLH patients were enrolled in this study. Among them, 20 were placed in the remission group, while 10 cases were placed in the death group. 6 cases died within 8 weeks due to the illness, and 4 cases died within 9 to 34 weeks. 30 children who were confirmed healthy after physical check-ups in the same period were enrolled in the control group. Peripheral blood was collected from both groups and lymphocyte subsets were studied using flow cytometry. RESULTS: The ratios of CD3+ T and CD8+ T cells increased in the HLH remission group and the death group, while CD4+, CD4+/CD8+ and CD3-CD16+ CD56+ NK ratios decreased. Difference detected in the proportion of CD19+ B cells was not statistically significant. By comparing lymphocyte subsets in the HLH acute period and the remission period in HLH patients we discovered that the differences in CD3+, CD8+, CD4+ and CD4+/CD8+, CD19+ B cells ratios were not statistically significant (p > 0.05). CD3-CD16+ CD56+ NK cells ratios in the remission period increased significantly. CONCLUSIONS: The lymphocyte subsets in children with HLH underwent obvious changes and there was an imbalance in cellular immunity. We believe that dynamic detection of changes may help us to evaluate the prognosis and the effect of the treatment.
- RetractionOpen Access
- 2 February 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (4) , 5391
[Retracted] Pediatric sarcomas (Review)
[This retracts the article DOI: 10.3892/ol.2017.7467.].
- 2 February 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (4) , 5391
RetractionOpen Access[Retracted] Pediatric sarcomas (Review)
[This retracts the article DOI: 10.3892/ol.2017.7467.].
- Open Access
- 31 May 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14 (1) , 478-482
Chronic conditions in adolescents
The health problems related to the nervous system are on rise in young infants leading to high mortality amongst this age group. A chronic medical condition (CC) is present in this age group to the tune of 10-20%. We searched the electronic database PubMed for pre-clinical as well as clinical controlled trials reporting variable chronic conditions especially in pediatric patients. Most of these reports revealed that type 1 diabetes mellitus is the most common CC in young infants. In female patients, metabolic control is often disturbed during CC in this age group. Poor metabolism regulation often results in long-term complications, including cognitive disorders. In cognitive disorders, memory loss and learning problems are the most among adolescents. Executive problems are observed to be associated with low physical activities. The review article concludes that knowledge about factors influencing treatment adherence is crucial in chronically ill infants. Further, we should focus on protective factors in order to prevent health risk behavior.
- 31 May 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14 (1) , 478-482
Open AccessChronic conditions in adolescents
The health problems related to the nervous system are on rise in young infants leading to high mortality amongst this age group. A chronic medical condition (CC) is present in this age group to the tune of 10-20%. We searched the electronic database PubMed for pre-clinical as well as clinical controlled trials reporting variable chronic conditions especially in pediatric patients. Most of these reports revealed that type 1 diabetes mellitus is the most common CC in young infants. In female patients, metabolic control is often disturbed during CC in this age group. Poor metabolism regulation often results in long-term complications, including cognitive disorders. In cognitive disorders, memory loss and learning problems are the most among adolescents. Executive problems are observed to be associated with low physical activities. The review article concludes that knowledge about factors influencing treatment adherence is crucial in chronically ill infants. Further, we should focus on protective factors in order to prevent health risk behavior.
- Open Access
- 28 April 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 10-14
Pediatric haematopoiesis and related malignancies
Survival after acute paediatric (0–14 years), adolescent (15–19 years) and young adult (20–39 years) leukaemia has improved substantially over the last five decades, particularly for acute lymphoblastic leukaemia (ALL) and acute promyelocytic leukaemia. This progress represents one of the most successful achievements in the history of medicine and has been attributed to the development of effective chemotherapy regimens, improvement in supportive care, better risk stratification, use of targeted therapies, and advances in haematopoietic stem cell transplantation. Recent studies have revealed improvement in survival over time for all age groups and subtypes of leukaemia. However, these outcomes varied widely by age and are associated with sociodemographic and clinical factors. The present review concludes that survival and early death after acute leukaemia has greatly improved among young patients. However, inequalities in outcomes remain and are likely a result of multiple factors.
- 28 April 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 10-14
Open AccessPediatric haematopoiesis and related malignancies
Survival after acute paediatric (0–14 years), adolescent (15–19 years) and young adult (20–39 years) leukaemia has improved substantially over the last five decades, particularly for acute lymphoblastic leukaemia (ALL) and acute promyelocytic leukaemia. This progress represents one of the most successful achievements in the history of medicine and has been attributed to the development of effective chemotherapy regimens, improvement in supportive care, better risk stratification, use of targeted therapies, and advances in haematopoietic stem cell transplantation. Recent studies have revealed improvement in survival over time for all age groups and subtypes of leukaemia. However, these outcomes varied widely by age and are associated with sociodemographic and clinical factors. The present review concludes that survival and early death after acute leukaemia has greatly improved among young patients. However, inequalities in outcomes remain and are likely a result of multiple factors.